Antibiotic resistance continues to push modern medicine into dangerous territory. In hospitals around the world, infections ...
Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Methicillin-resistant Staphylococcus Aureus (MRSA) Epidemiology Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. Studies ...
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market · GlobeNewswire Inc. Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs - Global ...
As strains of staph continue to adapt and change over time, it is critical for healthcare workers to track these changes. They need to know which strains are present within a community at any point in ...
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Industry has valued at US$ 3.9 billion in 2022 and is anticipated to grow to US$ 5.5 billion by 2030, with sales revenue set to ...
Deaths from Staphylococcus aureus–associated lower respiratory tract infections tripled from 1990 to 2021 worldwide.
In a new study, researchers show how so‑called TriPcides can target the bacterium Staphylococcus aureus, including antibiotic‑resistant strains such as MRSA. The compounds disrupt the bacteria's ...
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment Industry has valued at US$ 3.9 billion in 2022 and is anticipated to grow to US$ 5.5 billion by 2030, with sales revenue set to ...
Zacks Investment Research on MSN
Cumberland expands global reach with Vibativ launch in China
Cumberland Pharmaceuticals CPIX has expanded the international footprint of its antibiotic therapy Vibativ (telavancin) with its official launch in China. The move follows regulatory approval from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results